Procter & Gamble (NYSE:PG - Get Free Report) had its price objective reduced by stock analysts at Wells Fargo & Company from $173.00 to $170.00 in a research note issued on Thursday,Benzinga reports. The firm presently has an "overweight" rating on the stock. Wells Fargo & Company's price target indicates a potential upside of 10.74% from the company's previous close.
Other equities analysts have also recently issued reports about the stock. Evercore ISI reissued an "in-line" rating and issued a $170.00 price objective (down from $190.00) on shares of Procter & Gamble in a research note on Monday, July 14th. Berenberg Bank lifted their target price on shares of Procter & Gamble from $152.00 to $154.00 and gave the company a "hold" rating in a report on Wednesday, September 17th. JPMorgan Chase & Co. reissued a "neutral" rating and set a $170.00 price target (down from $178.00) on shares of Procter & Gamble in a report on Friday, July 25th. Barclays set a $164.00 price objective on Procter & Gamble and gave the company an "equal weight" rating in a report on Thursday, July 31st. Finally, BNP Paribas reissued an "outperform" rating and issued a $177.00 price target on shares of Procter & Gamble in a report on Friday, August 15th. One research analyst has rated the stock with a Strong Buy rating, ten have assigned a Buy rating and eight have given a Hold rating to the stock. Based on data from MarketBeat, the company currently has a consensus rating of "Moderate Buy" and an average price target of $173.78.
Read Our Latest Research Report on Procter & Gamble
Procter & Gamble Stock Up 0.7%
Shares of NYSE:PG opened at $153.52 on Thursday. The company has a current ratio of 0.70, a quick ratio of 0.49 and a debt-to-equity ratio of 0.49. The firm has a 50 day simple moving average of $156.12 and a 200-day simple moving average of $160.91. The company has a market capitalization of $359.30 billion, a PE ratio of 23.46, a P/E/G ratio of 4.02 and a beta of 0.36. Procter & Gamble has a twelve month low of $149.91 and a twelve month high of $180.43.
Procter & Gamble (NYSE:PG - Get Free Report) last released its quarterly earnings data on Tuesday, July 29th. The company reported $1.48 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.42 by $0.06. The company had revenue of $20.89 billion during the quarter, compared to the consensus estimate of $20.79 billion. Procter & Gamble had a net margin of 18.95% and a return on equity of 32.69%. Procter & Gamble's revenue for the quarter was up 1.7% on a year-over-year basis. During the same quarter in the prior year, the firm posted $1.40 earnings per share. Procter & Gamble has set its FY 2026 guidance at 6.830-7.090 EPS. On average, equities analysts predict that Procter & Gamble will post 6.91 EPS for the current fiscal year.
Insider Activity
In other Procter & Gamble news, COO Shailesh Jejurikar sold 13,039 shares of the stock in a transaction that occurred on Tuesday, August 19th. The shares were sold at an average price of $157.27, for a total value of $2,050,643.53. Following the completion of the sale, the chief operating officer owned 28,036 shares of the company's stock, valued at $4,409,221.72. This trade represents a 31.74% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, CEO Gary A. Coombe sold 10,194 shares of the firm's stock in a transaction on Thursday, August 21st. The shares were sold at an average price of $158.16, for a total transaction of $1,612,283.04. Following the sale, the chief executive officer directly owned 34,978 shares of the company's stock, valued at approximately $5,532,120.48. The trade was a 22.57% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 120,181 shares of company stock valued at $18,918,012 over the last quarter. 0.20% of the stock is owned by insiders.
Hedge Funds Weigh In On Procter & Gamble
A number of hedge funds have recently bought and sold shares of the company. Nova Wealth Management Inc. bought a new stake in shares of Procter & Gamble during the 1st quarter valued at about $26,000. Signature Resources Capital Management LLC boosted its position in Procter & Gamble by 67.9% during the 2nd quarter. Signature Resources Capital Management LLC now owns 178 shares of the company's stock valued at $28,000 after purchasing an additional 72 shares during the period. Quarry LP acquired a new stake in Procter & Gamble in the first quarter worth $33,000. Mizuho Securities Co. Ltd. lifted its stake in Procter & Gamble by 566.7% in the first quarter. Mizuho Securities Co. Ltd. now owns 200 shares of the company's stock valued at $34,000 after buying an additional 170 shares during the last quarter. Finally, Mid American Wealth Advisory Group Inc. bought a new position in Procter & Gamble in the 2nd quarter worth approximately $34,000. 65.77% of the stock is currently owned by institutional investors and hedge funds.
About Procter & Gamble
(
Get Free Report)
Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.
Further Reading

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Procter & Gamble, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Procter & Gamble wasn't on the list.
While Procter & Gamble currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.